Innovative design, highly versatile optical system for ENT and neurosurgery.
Carl Zeiss has created a special configuration of the OPMI pico surgical microscope for neurosurgical applications, combining the benefits of optical excellence and superb illumination with outstandi
The Leica MS1 F/MC1 F is designed to mount on the ceiling with a high degree of mobility. Its unique and patented suspension concept assures a superior stability and a perfect and steady microscope i
Neuro-Surgical microscope system has been designed to help the neurosurgeon minimize fatigue. The maneuverability of this system is such that it provides fatigue-free viewing even at the most difficu
Medicine Products:(Date:10/7/2008)... in North America) announced today the extension o... Inc., a leading nanotechnology co-development com...ny (Business Wire EON) October 7, 2008 -- The ori...n February 2007, was to develop innovative, nanote...ck,s materials. , , , After successfully meeting i...
(Date:10/7/2008)...e-USNewswire/ -- IPRO, one of the,nation,s leading... has,created a Limited Liability Company (LLC) tha...ight and consulting contracts with managed care,or...p://www.logiqual.com ), is now,officially incorpor...om.com/cgi-bin/prnh/20081007/DC37283LOGO-a ), (L...
(Date:10/7/2008)ANAHEIM, Calif., Oct. 7 /PRNewswire-USNewswire/ -- CHADD, the nation,s,largest organization serving people affected by AD/HD, will hold its Annual,International Conference on AD/HD November 12-1
(Date:10/7/2008)...of life after discharge, study finds , ,...cine for intensive care unit (ICU) patients may be...y,re able, a new report says. , Based on a rev...School of Medicine researchers concluded that the ...e unnecessary and long-term physical impairment an...
Breaking Medicine News(10 mins):Health News: Merck KGaA and Nano-Terra Announce Extension of Nanotechnology Solutions Alliance 2Health News: Merck KGaA and Nano-Terra Announce Extension of Nanotechnology Solutions Alliance 3Health News:IPRO Spins Off Managed Care Review Affiliate 2Health News:Early Mobility Best for ICU Patients 2...e British Medical Association was warned about the...s gambling addicts//. GP Jan Wise, from London a...equate steps are not being implemented to track do...he private sector should co operate with each othe...
...rking its first major investment into country's bo...DFC today said it has placed a private equity plac...alth Systems // , acquiring a minority stake in th...made by IDFC Private Equity Fund II, a fund manage...
...searchers have found that a protein known for driv...ole in restoring the ability of neurons to regener...ing spinal cord damage or neurological diseases li...that the same process this protein uses for prolif...
...cording to a new research, avoiding house dust mit...ed the onset of asthma//, eczema or atopy in high-...increasing the consumption of fish rich in omega-3...be ineffective in children with a family history o...
Other Medicine News:Health News:Preventive Measures Proved Ineffective in Allergic Children 2(Date:10/7/2008)... SAN DIEGO, Oct. 7 /- Prometheus Lab..., today announced findings from its,development of...blood test,for irritable bowel syndrome (IBS). The...pression of particular biomarkers in blood samples...ion of these biomarkers,combined with a proprieta...
(Date:10/7/2008)... AUSTIN, Texas, Oct. 7 /- The Texas ... Medical Center has been selected as one of,only a...approved clinical,trial for a new device to treat ...onal treatment, training and research center speci...p between St. David,s Medical Center and,Texas Car...
(Date:10/7/2008)...Study Showed Larazotide Acetate Prevented Immunolo...atients with Celiac Disease, Additional Data Indic...ase, ORLANDO, Fla., Oct. 7 /- Alba T... clinical studies this week at the American,Colleg... Meeting. Data from,study CLIN 1001-004, the first...
(Date:10/7/2008)... FORT COLLINS, Colo., Oct. 7 /- A st...mining embryonic stem cell self-renewal,reported ...tim (recombinant,human serum albumin) was an effec...l culture., The article entitled, "The ground sta... that researchers used Cellastim as a recombinant,...
Breaking Medicine Technology:Prometheus Presents Findings From Development of PROMETHEUS(R) IBS Diagnostic, First Blood Test for IBS, at ACG Annual Scientific Meeting 2Prometheus Presents Findings From Development of PROMETHEUS(R) IBS Diagnostic, First Blood Test for IBS, at ACG Annual Scientific Meeting 3Texas Cardiac Arrhythmia Institute at St. David's Medical Center Selected to Conduct Clinical Trial for Device to Treat Atrial Fibrillation 2Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 2Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 3Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 4Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 5Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 6Iomai Announces Publication in The Lancet of Phase II Study Demonstrating Significant Efficacy of Travelers Diarrhea Vaccine 2397 1Iomai Announces Publication in The Lancet of Phase II Study Demonstrating Significant Efficacy of Travelers Diarrhea Vaccine 2397 2Iomai Announces Publication in The Lancet of Phase II Study Demonstrating Significant Efficacy of Travelers Diarrhea Vaccine 2397 3Iomai Announces Publication in The Lancet of Phase II Study Demonstrating Significant Efficacy of Travelers Diarrhea Vaccine 2397 4Iomai Announces Publication in The Lancet of Phase II Study Demonstrating Significant Efficacy of Travelers Diarrhea Vaccine 2397 5Iomai Announces Publication in The Lancet of Phase II Study Demonstrating Significant Efficacy of Travelers Diarrhea Vaccine 2397 6Iomai Announces Publication in The Lancet of Phase II Study Demonstrating Significant Efficacy of Travelers Diarrhea Vaccine 2397 7St Joseph Health System Caregivers Demand Foley 26 Lardner Stop Intimidation and Waste of Valuable Patient Care Resources 21632 1St Joseph Health System Caregivers Demand Foley 26 Lardner Stop Intimidation and Waste of Valuable Patient Care Resources 21632 2New Survey Demonstrates Increased Awareness of the Dangers of Meth Use 21628 1New Survey Demonstrates Increased Awareness of the Dangers of Meth Use 21628 2New Survey Demonstrates Increased Awareness of the Dangers of Meth Use 21628 3New Survey Demonstrates Increased Awareness of the Dangers of Meth Use 21628 4Jazz Pharmaceuticals Files Form S 3 Registration Statements 5944 1Jazz Pharmaceuticals Files Form S 3 Registration Statements 5944 2Jazz Pharmaceuticals Files Form S 3 Registration Statements 5944 3...l 3, 2007 - Nymox,Pharmaceutical Corporation (NASD...sults from the Company,s studies of NX-1207 for,be... at the New,England Section of the American Urolog...he paper is authored by leading clinical,research ..., The Company previously completed three U.S. tria...
...tential of microRNAs as,Novel Cancer Drug Targets,...July 05, 2007,/PRNewswire-FirstCall/ -- Rosetta Ge... today research published in the journal,Molecular... Science,and Rosetta Genomics . The findings sugge...miR-34a) to be used as a drug candidate,in cancer ...
Other Medicine Technology:Clinical Data From Nymox BPH Drug To Be Presented at American,Urological Association Meeting 2Rosetta Genomics and Weizmann Institute Scientists Identify Role of,microRNA in Cancer Suppression 2Rosetta Genomics and Weizmann Institute Scientists Identify Role of,microRNA in Cancer Suppression 3Rosetta Genomics and Weizmann Institute Scientists Identify Role of,microRNA in Cancer Suppression 4Rosetta Genomics and Weizmann Institute Scientists Identify Role of,microRNA in Cancer Suppression 5